NEW YORK (GenomeWeb News) – Palo Alto, Calif.-based nanoproteomics company Cell Biosciences announced today that it has placed a prototype of a next-generation protein analysis system at Stanford University’s School of Medicine.
 
The company said that David Hirschberg, director of Stanford’s Human Immune Monitoring Center, will use Cell Biosciences’ CB1000 system for analyzing human clinical samples and will provide feedback aimed at improving product design and optimizing system features.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.